NFG
SVA

Next Financial Group’s Sinovac Biotech, Ltd SVA Stock Holding History

Next Financial Group’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$0 Buy
17
+1
+6% – ﹤0.01% 3064
2021
Q3 		$0 Hold
16
– – ﹤0.01% 2877
2021
Q2 		$0 Hold
16
– – ﹤0.01% 2776
2021
Q1 		$0 Hold
16
– – ﹤0.01% 2700
2020
Q4 		$0 Hold
16
– – ﹤0.01% 2478
2020
Q3 		$0 Buy
+16
New – ﹤0.01% 2240
2020
Q2 		– Sell
-16
Closed – – 2174
2020
Q1 		$0 Hold
16
– – ﹤0.01% 2548
2019
Q4 		$0 Hold
16
– – ﹤0.01% 2616
2019
Q3 		$0 Hold
16
– – ﹤0.01% 2521
2019
Q2 		$0 Hold
16
– – ﹤0.01% 2470
2019
Q1 		$0 Buy
+16
New +$105 ﹤0.01% 2317

Other funds holding SVA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Next Financial Group's SVA Position: Q4 2021 in Review

Next Financial Group increased its Sinovac Biotech, Ltd (SVA) stake by 6.3% in Q4 2021, adding 1 share and bringing the position to 17 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3064.

Next Financial Group first reported a position in SVA in Q1 2019 and has held it in 11 quarters since. 29 funds tracked by Wall St. Rank hold SVA as of Q4 2021.

  • Next Financial Group held 17 shares of Sinovac Biotech, Ltd worth $0 as of Q4 2021.
  • Next Financial Group bought 1 Sinovac Biotech, Ltd share in Q4 2021.
  • Sinovac Biotech, Ltd made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #3064 holding.
  • Next Financial Group first reported a position in Sinovac Biotech, Ltd in Q1 2019 and has held it in 11 quarters since.
  • 29 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.